These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34820372)

  • 1. Identification of the Pyroptosis-Related Gene Signature for Overall Survival Prediction in Patients With Hepatocellular Carcinoma.
    Liu S; Shao R; Bu X; Xu Y; Shi M
    Front Cell Dev Biol; 2021; 9():742994. PubMed ID: 34820372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel association of pyroptosis-related gene signature with the prognosis of hepatocellular carcinoma.
    Li Y; Li Y; Zhang X; Duan X; Feng H; Yu Z; Gao Y
    Front Oncol; 2022; 12():986827. PubMed ID: 36267972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and Validation of Pyroptosis-Related Gene Signature to Predict Prognosis and Reveal Immune Infiltration in Hepatocellular Carcinoma.
    Fu XW; Song CQ
    Front Cell Dev Biol; 2021; 9():748039. PubMed ID: 34820376
    [No Abstract]   [Full Text] [Related]  

  • 4. Pyroptosis related genes signature predicts prognosis and immune infiltration of tumor microenvironment in hepatocellular carcinoma.
    Fang G; Zhang Q; Fan J; Li H; Ding Z; Fu J; Wu Y; Zeng Y; Liu J
    BMC Cancer; 2022 Sep; 22(1):999. PubMed ID: 36127654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive genomic signature of pyroptosis-related genes and relevant characterization in hepatocellular carcinoma.
    Wang S; Gao S; Shan L; Qian X; Luan J; Lv X
    PeerJ; 2023; 11():e14691. PubMed ID: 36650832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel pyroptosis-regulated gene signature for predicting prognosis and immunotherapy response in hepatocellular carcinoma.
    Zhang B; Wang Z
    Front Mol Biosci; 2022; 9():890215. PubMed ID: 36262473
    [No Abstract]   [Full Text] [Related]  

  • 7. A novel risk score model based on pyroptosis-related genes for predicting survival and immunogenic landscape in hepatocellular carcinoma.
    Wang H; Zhang B; Shang Y; Chen F; Fan Y; Tan K
    Aging (Albany NY); 2023 Feb; 15(5):1412-1444. PubMed ID: 36920176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic signature for hepatocellular carcinoma based on 4 pyroptosis-related genes.
    Duan S; Gao J; Lou W; Zhang Y; Deng Y; Wang C; Huang H; Xu H; Guo S; Lai S; Xi F; Li Z; Deng L; Zhong Y
    BMC Med Genomics; 2022 Jul; 15(1):166. PubMed ID: 35902905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyroptosis-Related Risk Signature Exhibits Distinct Prognostic, Immune, and Therapeutic Landscapes in Hepatocellular Carcinoma.
    Zhao Y; Song Q; Xu F; Zhou Y; Zuo X; Zhang Z
    Front Genet; 2022; 13():823443. PubMed ID: 35368686
    [No Abstract]   [Full Text] [Related]  

  • 10. A pyroptosis-related gene signature predicts prognosis and immune microenvironment in hepatocellular carcinoma.
    Jin Y; Pu X; Ping D; Huang C; Ding G; Cao L
    World J Surg Oncol; 2022 Jun; 20(1):179. PubMed ID: 35659304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the Pyroptosis-Related Prognosis Gene Signature and Immune Infiltration in Hepatocellular Carcinoma.
    Yu H; Bai X; Zheng W
    Dis Markers; 2022; 2022():9124216. PubMed ID: 35535333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Pyroptosis-related Prognostic Model for Hepatocellular Carcinoma.
    Wu Q; Jiang S; Cheng T; Xu M; Lu B
    Front Cell Dev Biol; 2021; 9():770301. PubMed ID: 34869364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and validation of a pyroptosis-related gene signature in hepatocellular carcinoma based on RNA sequencing.
    He J; Ran J; Li J; Chen D
    Transl Cancer Res; 2022 Jun; 11(6):1510-1522. PubMed ID: 35836524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a Pyroptosis-Related Prognostic Signature Combined With Experiments in Hepatocellular Carcinoma.
    Li H; Li T; Zhang X
    Front Mol Biosci; 2022; 9():822503. PubMed ID: 35309514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and in vitro and in vivo validation of the key role of GSDME in pyroptosis-related genes signature in hepatocellular carcinoma.
    Chen X; Yang M; Wang L; Wang Y; Tu J; Zhou X; Yuan X
    BMC Cancer; 2023 May; 23(1):411. PubMed ID: 37149620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pyroptosis-related gene signature for prognosis prediction in hepatocellular carcinoma.
    Chen Y; Zhu Y; Dong Y; Li H; Gao C; Zhu G; Mi X; Li C; Xu Y; Wang G; Cai S; Han Y; Xu C; Wang W; Yang S; Ji W
    Front Oncol; 2023; 13():1085188. PubMed ID: 37051536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of a Pyroptosis-Related Signature for Prognostic Prediction and Characterization of Immune Microenvironment in Acute Myelogenous Leukemia.
    Liu S; Luo D; Luo J; Liang H; Zhi Y; Wang D; Xu N
    Int J Gen Med; 2022; 15():2913-2927. PubMed ID: 35308573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signature Construction and Molecular Subtype Identification Based on Pyroptosis-Related Genes for Better Prediction of Prognosis in Hepatocellular Carcinoma.
    Chen J; Tao Q; Lang Z; Gao Y; Jin Y; Li X; Wang Y; Zhang Y; Yu S; Lv B; Yu Z; Lin C
    Oxid Med Cell Longev; 2022; 2022():4494713. PubMed ID: 35069975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Pyroptosis-Related Gene Signature Predicts Prognosis and Immune Microenvironment for Breast Cancer Based on Computational Biology Techniques.
    Wang Z; Bao A; Liu S; Dai F; Gong Y; Cheng Y
    Front Genet; 2022; 13():801056. PubMed ID: 35464869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and Validation of a Novel Pyroptosis-Related Gene Signature for Prognosis Prediction in Soft Tissue Sarcoma.
    Qi L; Xu R; Wan L; Ren X; Zhang W; Zhang K; Tu C; Li Z
    Front Genet; 2021; 12():773373. PubMed ID: 34925457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.